US-guided cholecystostomy: a retrospective study of indications, complications and outcome

• Autor(a) principal: Vilaverde, Filipa
• Data de Publicação: 2017
• Outros Autores: Sousa, Marta, Mesquita, Romeu, Pinto, Joana, Reis, Alcinda
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.25748/arp.13251
• topic: Artigos Originais

We aimed to review the use of US-guided percutaneous cholecystostomy (PC) in our hospital: the indications, complications and outcomes. We retrospectively reviewed consecutive PC procedures performed at our institution from January 2010 to December 2012. Sixty-five patients (36 male, 29 female; mean age 75 years) underwent 70 US-guided PC, mainly in the context of acute cholecystitis (62/65 – 95,4%). The diagnosis of acute cholecystitis was confirmed just by US in 32/62 (51,6%). The main indications for PC were the persistence of clinical and/or laboratory findings after antibiotherapy institution and the presence of comorbidities. The transhepatic procedure was considered technically successful in 69/70 (98,6%) cases. We had 2/70 (2,8%) major complications (1biliary peritonitis; 1 fatal abdominal wall abscess with sepsis) and 7/70 (10,0%) minor complications (6 dislodgements; 1 phrenic nerve irritation). Thirty-day mortality was 6,2% (4 patients, 1 procedure related). The average duration of catheter drainage was 21,4 days (range, 2-60 days). Subsequently, 24/65 (36,9%) patients underwent elective cholecystectomy (mean 4 months, range 1,5-10). Recurrent acute cholecystitis occurred in 8/65 (12,3%) patients during the follow-up. US-guided PC is a viable option for treating acute cholecystitis in some specific clinical settings.